Q4 2025 MSO Earnings Recap: Who Beat Estimates?

The Q4 2025 earnings season for multi-state operators (MSOs) painted a picture of an industry in transition, where operational discipline has replaced breakneck expansion as the primary driver of investor confidence. After years of prioritizing market share gains, the largest US cannabis operators focused on margin expansion, cost optimization, and cash flow generation throughout 2025, with mixed results that reflected both the challenges and opportunities in America's evolving cannabis landscape.

Revenue Performance: Growth Moderates Across the Board

The top-tier MSOs reported aggregate revenue growth of 8.2% year-over-year in Q4 2025, marking the slowest growth rate since the industry's early expansion phase. Curaleaf Holdings (CURLF) led the pack with Q4 revenue of $387 million, representing a 12% increase from the prior year quarter but a 3% sequential decline from Q3 2025. The company's performance was bolstered by strong results in New York and Pennsylvania, offsetting weakness in Florida following increased competition.

Green Thumb Industries (GTBIF) reported Q4 revenue of $298 million, up 7% year-over-year but down 1% sequentially. The company's Rise retail network continued to demonstrate resilience, with same-store sales growth of 4.2% despite market saturation in key states like Illinois and Pennsylvania.

Trulieve Cannabis (TCNNF) faced the steepest headwinds, with Q4 revenue of $315 million representing just 2% growth year-over-year and a 6% sequential decline. The Florida-focused operator struggled with increased competition in its home market, where adult-use legalization efforts stalled and medical patient growth plateaued at 850,000 registered users.

"We're seeing a fundamental shift from the land-grab mentality to operational excellence. Companies that can demonstrate sustainable margin expansion are being rewarded by the market." - Cannabis industry analyst Sarah Chen

Verano Holdings (VRNOF) surprised to the upside with Q4 revenue of $245 million, beating consensus estimates by 4% and showing 9% year-over-year growth. Strong performance in New Jersey and Illinois drove the beat, with the company's premium Encore brand gaining significant market share.

Cresco Labs (CRLBF) rounded out the group with Q4 revenue of $201 million, flat year-over-year but representing a 5% sequential improvement driven by operational efficiency gains and portfolio optimization.

Margin Expansion Takes Center Stage

The standout theme across Q4 2025 earnings was gross margin expansion, with four of the five major MSOs posting improved profitability metrics. Green Thumb led the way with gross margins of 58.2%, up 420 basis points year-over-year, driven by cultivation efficiency improvements and a shift toward higher-margin retail operations.

Curaleaf achieved gross margins of 54.8%, up 380 basis points from Q4 2024, as the company's Project Canopy cost reduction initiative delivered $45 million in annual savings. The program included facility consolidations, automation investments, and workforce optimization across 23 states.

Trulieve, despite revenue headwinds, posted its highest-ever gross margin of 61.1%, up 290 basis points year-over-year. The company's focus on premium products and vertical integration continued to pay dividends, with manufacturing costs declining 15% per gram produced.

Verano's gross margins reached 52.7%, improving 350 basis points as the company benefited from scale efficiencies and strategic market exits. The operator closed underperforming assets in three states while doubling down on high-growth markets like New Jersey and Pennsylvania.

Only Cresco Labs saw margin compression, with gross margins declining to 49.2% from 52.1% in the prior year quarter, primarily due to inventory write-downs related to legacy cultivation facilities.

Earnings Beats and Misses: The Winners and Losers

Analyst expectations proved challenging to meet, with only two of the five major MSOs beating consensus estimates on both revenue and adjusted EBITDA.

Green Thumb Industries delivered the strongest performance relative to expectations, beating revenue estimates by 2.8% and adjusted EBITDA estimates by 11%. The company reported Q4 adjusted EBITDA of $89 million, representing a margin of 29.9% and marking the highest quarterly profitability in company history.

Verano Holdings also outperformed, beating revenue estimates by 3.7% and posting adjusted EBITDA of $71 million, ahead of consensus by 8%. The company's focus on operational efficiency and strategic market positioning drove the outperformance.

Curaleaf met revenue expectations but fell short on profitability, with adjusted EBITDA of $78 million coming in 5% below estimates due to higher-than-expected integration costs from recent acquisitions.

Trulieve disappointed on both metrics, missing revenue estimates by 4.2% and adjusted EBITDA expectations by 7%. Despite strong margins, the company's Florida-heavy footprint proved a liability as competitive pressures intensified.

Cresco Labs missed on revenue but surprised with adjusted EBITDA of $45 million, beating estimates by 6% as cost-cutting measures more than offset top-line weakness.

Cash Flow Generation Becomes Key Metric

Free cash flow generation emerged as a critical differentiator in Q4 2025, with investors placing increased emphasis on companies' ability to self-fund growth and return capital to shareholders. Green Thumb led the group with $52 million in free cash flow, enabling the company to reduce net debt by $78 million during the quarter.

Curaleaf generated $31 million in free cash flow despite elevated capital expenditures, while Verano posted $28 million. Both Trulieve and Cresco Labs achieved positive free cash flow for the first time in over two years, generating $19 million and $12 million respectively.

State Market Dynamics Drive Performance Divergence

State-level market conditions played a crucial role in determining Q4 2025 performance across the MSO landscape. New York's adult-use market maturation benefited operators with established footprints, while Florida's medical-only market showed signs of saturation.

In New York, wholesale prices stabilized around $2,800 per pound after declining 40% in 2024, providing better visibility for cultivation-focused operators. Green Thumb and Curaleaf both reported strong performance in the Empire State, with retail locations generating average monthly revenue of $1.2 million.

Pennsylvania remained a bright spot, with limited license availability supporting healthy margins. Trulieve's 23 dispensaries in the state generated $47 million in Q4 revenue, representing 15% of total company sales from just 7% of retail locations.

Illinois showed maturity with declining growth rates but stable profitability. Green Thumb's 14 locations in the Prairie State averaged $950,000 in monthly revenue, down from peak levels but maintaining strong margins above 35%.

Florida's challenges became increasingly apparent, with patient count growth slowing to just 2.3% year-over-year and average transaction sizes declining 8% as competition intensified among the state's 25 licensed operators.

Management Outlook: Cautious Optimism for 2026

Management teams across the major MSOs expressed cautious optimism for 2026, citing improving state-level dynamics and operational efficiency gains. Green Thumb's management guided to revenue growth of 6-10% for 2026, with continued margin expansion expected as the company completes its footprint optimization.

Curaleaf projected revenue growth in the high-single digits, emphasizing the company's focus on markets with favorable regulatory dynamics and limited license availability. Management highlighted potential catalysts including New York market maturation and possible federal scheduling changes.

Trulieve's guidance proved most conservative, with management projecting flat to low-single-digit revenue growth while maintaining margin expansion targets. The company emphasized potential upside from Florida adult-use legalization, though no timeline was provided.

Verano's management guided to double-digit revenue growth in 2026, driven by new market entries and capacity expansion in high-growth states. The company allocated $85 million for capital expenditures focused on cultivation efficiency and retail expansion.

Cresco Labs projected modest revenue growth while emphasizing continued cost optimization and potential strategic alternatives for underperforming assets.

"The industry has reached an inflection point where sustainable profitability matters more than top-line growth. Companies that can demonstrate both operational discipline and strategic market positioning will outperform in 2026." - MSO CFO commentary

Key Takeaways

• Margin expansion dominated Q4 2025 results, with four of five major MSOs posting improved gross margins through operational efficiency and cost optimization • Green Thumb and Verano emerged as the quarter's clear winners, beating both revenue and profitability estimates while generating strong free cash flow • State market dynamics created significant performance divergence, with New York and Pennsylvania strength offsetting Florida headwinds • Free cash flow generation became a key investor focus, with all five MSOs achieving positive operating cash flow for the first time collectively • 2026 guidance reflects cautious optimism, with management teams prioritizing sustainable profitability over aggressive growth as the industry matures